CNS Pharmaceuticals Q2 EPS $(6.42) Beats $(9.60) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(6.42) per share which beat the analyst consensus estimate of $(9.60) by 33.13 percent. This is a 98.09 percent increase over losses of $(336.00) per share
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(6.42) per share which beat the analyst consensus estimate of $(9.60) by 33.13 percent. This is a 98.09 percent increase over losses of $(336.00) per share from the same period last year.